Publication
Logo
Avatar
r363l l10n @r363ll10n

🔴Pfizer “basically hasn’t bothered to test its booster at all in the people who are actually at risk.” In fact, it only conducted a single “phase 1” trial that covered 12 people over age 65. — Alex Berenson, former NY Times reporter https://bit.ly/3EsYU8C

#TheDefender: SIGN UP TODAY--> https://bit.ly/2Qi3Qc8

FDA Scientists Skeptical Over Need for Boosters, Citing Lack of Verified Data Ahead of Friday Advisory Meeting • Children's Health Defense

In a 23-page report released Wednesday, FDA officials said, based on their analysis of data submitted by Pfizer and BioNTech, they could not yet take a stance on whether to recommend COVID boosters for the general public.

https://bit.ly/3EsYU8C

Only people mentioned by @r363ll10n in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from r363l l10n, click on at the bottom under it